The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for hormone therapy and your health.

Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta Therapeutics adds a black box warning to the gene therapy for acute liver injury and failure and parts with more than a third of employees.